Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease

Diabetic kidney disease (DKD) is the main complication in diabetes mellitus (DM) and the main cause of end-stage kidney disease worldwide. However, sodium glucose cotransporter 2 (SGLT2) inhibition, glucagon-like peptide-1 (GLP-1) receptor agonist, mineralocorticoid receptor antagonists and endothel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xian, Dai, Wenni, Li, Hao, Yan, Zhe, Liu, Zhiwen, He, Liyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809356/
https://www.ncbi.nlm.nih.gov/pubmed/36576203
http://dx.doi.org/10.1080/10717544.2022.2160518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809356/
https://www.ncbi.nlm.nih.gov/pubmed/36576203
http://dx.doi.org/10.1080/10717544.2022.2160518

Ejemplares similares